The antibody test will determine whether someone has been infected with and recovered from COVID-19. The CDC has said that as many as 25 percent to 50 percent of people with COVID-19 might not show symptoms, so antibody tests can help determine the full spread of the virus.
Antibody tests also can help determine if antibodies provide protection against reinfection and support development of treatments and vaccines, according to Forbes.
Abbott said after sending the first million tests this week, it will ramp up production and send 4 million tests by the end of the month. By June, the company said it will ship 20 million tests per month.
Read the full news release here.
More articles on supply chain:
COVID-19 testing in the US: 6 questions answered
US doubles hospital payments to speed processing of Abbott COVID-19 tests
Create a national distribution system for protective gear, AMA urges
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
